LakeShore Biopharma Co., Ltd (LSB:NASDAQ) closed at $0.627 on July 7, 2026, unchanged on the day. The stock trades 92.7% below its 52-week high of $8.60 and 9.2% above its 52-week low of $0.574. LakeShore Biopharma Co., Ltd is part of the Health Care sector.
In 252 trading sessions since October 14, 2025, LSB closed higher on 0 days (0%). Its best day was October 14, 2025 (0.00%) and its worst was October 14, 2025 (0.00%). It never moved 10% or more in a single session. It opened at least 5% above the previous day's high 252 times.
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminum-free lyophilized rabies vaccine that was launched in China.
Find more stocks like LSB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.